We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novo Nordisk Takes On Sanofi Over Insulin Pens

Law360 (July 17, 2007, 12:00 AM EDT) -- Denmark-based drug maker Novo Nordisk A/S has filed a suit against Sanofi-Aventis and its U.S. affiliate for allegedly infringing an injection device patent through the French pharmaceutical company's yet-to-be-launched insulin pen...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.